Deregulated Expression of Aurora Kinases Is Not a Prognostic Biomarker in Papillary Thyroid Cancer Patients |
| |
| Authors: | Enke Baldini Chiara Tuccilli Natalie Prinzi Salvatore Sorrenti Laura Falvo Corrado De Vito Antonio Catania Francesco Tartaglia Renzo Mocini Carmela Coccaro Stefania Alessandrini Susi Barollo Caterina Mian Alessandro Antonelli Enrico De Antoni Massimino D’Armiento Salvatore Ulisse |
| |
| Affiliation: | 1. Department of Experimental Medicine, “Sapienza” University of Rome, Rome, Italy.; 2. Department of Surgical Sciences, “Sapienza” University of Rome, Rome, Italy.; 3. Department of Public Health and Infectious Diseases, “Sapienza” University of Rome, Rome, Italy.; 4. Department of Medicine, University of Padua, Padua, Italy.; 5. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; University of L''Aquila, ITALY, |
| |
| Abstract: | A number of reports indicated that Aurora-A or Aurora-B overexpression represented a negative prognostic factor in several human malignancies. In thyroid cancer tissues a deregulated expression of Aurora kinases has been also demonstrated, butno information regarding its possible prognostic role in differentiated thyroid cancer is available. Here, weevaluated Aurora-A and Aurora-B mRNA expression and its prognostic relevance in a series of 87 papillary thyroid cancers (PTC), with a median follow-up of 63 months. The analysis of Aurora-A and Aurora-B mRNA levels in PTC tissues, compared to normal matched tissues, revealed that their expression was either up- or down-regulatedin the majority of cancer tissues. In particular, Aurora-A and Aurora-B mRNA levels were altered, respectively, in 55 (63.2%) and 79 (90.8%) out of the 87 PTC analyzed.A significant positive correlation between Aurora-A and Aurora-B mRNAswas observed (p=0.001). The expression of both Aurora genes was not affected by the BRAFV600E mutation. Univariate, multivariate and Kaplan-Mayer analyses documented the lack of association between Aurora-A or Aurora-B expression and clinicopathological parameterssuch as gender, age, tumor size, histology, TNM stage, lymph node metastasis and BRAF status as well asdisease recurrences or disease-free interval. Only Aurora-B mRNA was significantly higher in T(3-4) tissues, with respect to T(1-2) PTC tissues. The data reported here demonstrate that the expression of Aurora kinases is deregulated in the majority of PTC tissues, likely contributing to PTC progression. However, differently from other human solid cancers, detection of Aurora-A or Aurora-B mRNAs is not a prognostic biomarker inPTC patients. |
| |
| Keywords: | |
|
|
